The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us?

Thromb Haemost. 2014 Nov;112(5):860-7. doi: 10.1160/TH14-03-0199. Epub 2014 Sep 18.

Abstract

Several haemostatic factors have been associated with incident arterial cardiovascular disease in prospective studies and meta-analyses. Plasma fibrinogen shows a strong and consistent association with risk; however, this may reflect its inflammatory marker status, and causality remains to be proven. The common haemostatic gene polymorphisms for factor II, factor V and the von Willebrand factor: Factor VIII (non-O blood group) show significant associations with coronary heart disease (CHD) risk, consistent with potential causality. Increased D-dimer and t-PA antigen levels are associated with CHD risk, suggesting roles for coagulation activation and endothelial disturbance. There is little evidence for associations with CVD with other haemostatic factors.

Keywords: Arterial thrombosis; coagulation factors; epidemiological studies.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood*
  • Blood Coagulation Factors / analysis
  • Blood Coagulation* / physiology
  • Blood Proteins / analysis*
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / epidemiology
  • Fibrinogen / analysis
  • Humans
  • Inflammation / blood
  • Platelet Activation
  • Prospective Studies
  • Risk Factors

Substances

  • Biomarkers
  • Blood Coagulation Factors
  • Blood Proteins
  • Fibrinogen